ImmunityBio, Inc 10-Q for FY2020 Q3
ImmunityBio, Inc. (IBRX)
10-Q
2020-11-09
For: 2020-09-30
View Original
Added on
April 10, 2026
About this 10-Q
ImmunityBio, Inc filed this 10-Q on November 9, 2020, covering the quarter ended September 30, 2020 (FY2020 Q3).
Headline figures
Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $68K
- up 466.7% from $12K a year earlier
- Net loss
- $21.78M
- compared with a net loss of $15.58M a year earlier